117 results on '"Chapple C"'
Search Results
2. Nocturia: risk factors and associated comorbidities; findings from the EpiLUTS study
3. Functional and radioligand binding characterization of the α1L-adrenoceptor subtype of the human vas deferens
4. Tissue engineered buccal mucosa for urethroplasty: Progress and future directions☆
5. Tissue engineered buccal mucosa for urethroplasty: Progress and future directions☆
6. Is there a link between overactive bladder and the metabolic syndrome in women? A systematic review of observational studies
7. OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies used or reason for inadequate management of overactive bladder
8. Safety and tolerability of the β3-adrenoceptor agonist mirabegron, for the treatment of overactive bladder: results of a prospective pooled analysis of three 12-week randomised Phase III trials and of a 1-year randomised Phase III trial
9. Contemporary issues with pharmacotherapy for lower urinary tract symptoms
10. Urgency and pain in patients with overactive bladder and bladder pain syndrome. What are the differences?
11. Phase II Study on the Efficacy and Safety of the EP1 Receptor Antagonist ONO-8539 for Nonneurogenic Overactive Bladder Syndrome
12. The burden of urgency urinary incontinence on health and wellbeing
13. Current issues in managing men with lower urinary tract symptoms in primary care
14. Erectile dysfunction and lower urinary tract symptoms: a consensus on the importance of co-diagnosis
15. Evaluation and Treatment of Lower Urinary Tract Symptoms in Older Men
16. Nocturia: current concepts and future perspectives
17. Urinary incontinence – a challenge to the physiologist Joint symposium for the EU/FP7 networks INComb and TRUST in collaboration with the Swedish Enuresis Academy (SEA), Stockholm 2011
18. Improving perinatal mental health literacy in remote Aboriginal communities in the Northern Territory
19. Lower urinary tract symptoms revisited
20. Tissue Engineered Oral Mucosa for Urethroplasty: Past Experience and Future Directions
21. Editorial comment regarding diagnostic value of International Prostate Symptom Score (IPSS) voiding-to-storage subscore ratio in male lower urinary tract symptoms
22. Antimuscarinics for treatment of storage lower urinary tract symptoms in men: a systematic review
23. New once-daily formulation for trospium in overactive bladder
24. Antimuscarinic agents in elderly people
25. Assessing patientsʼ descriptions of lower urinary tract symptoms (LUTS) and perspectives on treatment outcomes: results of qualitative research
26. Nocturia: not just the elderly
27. Nocturia and the danger of falls
28. A stepwise approach to the treatment of the enlarged prostrate
29. A Multicenter, Double-Blind, Randomized, Parallel Group Study Comparing Polyvinyl Chloride and Polyvinyl Chloride-Free Catheter Materials
30. Urinary urgency – translating the evidence base into daily clinical practice
31. Evaluation and Treatment of Lower Urinary Tract Symptoms in Older Men
32. Overactive Bladder and Continence Guidelines: implementation, inaction or frustration?
33. Itʼs just the worry about not being able to control it! A qualitative study of living with overactive bladder
34. Diagnosis and treatment of lower urinary tract symptoms suggestive of overactive bladder and bladder outlet obstruction among men in general practice in the UK
35. Bladder afferent sensitivity in wild-type and TRPV1 knockout mice
36. The contemporary pharmacological management of overactive bladder
37. The contemporary pharmacological management of overactive bladder
38. The emerging role of intravesical botulinum toxin therapy in idiopathic detrusor overactivity
39. Botulinum toxin injection therapy in the management of lower urinary tract dysfunction
40. Overactive bladder: the importance of new guidance
41. Solifenacin significantly improves all symptoms of overactive bladder syndrome
42. Muscarinic receptor function, density and G-protein coupling in the overactive diabetic rat bladder
43. Nocturia: morbidity and management in adults
44. Pharmacotherapy for overactive bladder
45. Urological diagnosis: history, examination and investigations
46. Urinary incontinence in adults
47. Identification of epithelial auto-antigens associated with periodontal disease
48. Towards patient-driven criteria in overactive bladder management
49. Consensus statement on urethral trauma
50. Buccal mucosal urethroplasty: is it the new gold standard?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.